"The Effect Of The Dyevert Plus Contrast Reduction System On Cases Of Transcatheter Aortic Valve Replacement (TAVR)
Presenter
Ali Farooq, M.D, Charleston Area Medical Center, CHARLESTON, WV
Frank Annie, PhD, CAMC Health Education and Research Institute, Charleston, SC, Ali Farooq, M.D, Charleston Area Medical Center, CHARLESTON, WV, Sarah B Embrey, PharmD, University of Charleston, Charleston, WV and Aravinda Nanjundappa, M.B.B.S., FSCAI, Cleveland Clinic Main Campus, Cleveland, OH
Keywords: TAVI/TAVR/Aortic Valve
Background
We sought to assess the impact of the Dyevert Plus system on cases of transcatheter aortic valve replacement (TAVR).
Methods
We identified adult patients that had received a TAVR at Charleston Medical Center from Jun 1
st 2020 - August 31
th 2020 that had utilized the Dyevert Plus system. We sought to understand the effect on AKI post procedure within 7 days and tracked the cases for 90 days. We identified (n=13) cases and recorded general demographics data as well as the amount of contrast used in each case as well as differing valve types and sizes.
Results
The average age was 73.4 years old with (5) males and (8) females. The average glomerular filtration rate (GFR) before the cases was (38.4 ml/min), the before procedure creatinine was (1.6 mg/dL) and the post procedure creatinine was (1.8 mg/dL). The attempted average volume of contrast was (74.6 mL), the average volume to patients was (45.5 ml) which translates to a reduced volume percentage of (36.4%). The average length of stay was 4.6 days. We observed a 7 day AKI rate of 0%. One readmission was observed within 30 days as a result of bleeding. Also one death was recorded after the patient was transferred to another facility.
Conclusions
In a single center review of patients treated at Charleston Area Medical Center we observed no cases of AKI in TAVR cases when used in conjunction with the Dyevert Plus system.